Yoshikatsu Kanai
Suita, 5650871, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
A Sensitive, Specific, and Cost-Effective Lauroylation-Assisted Workflow for Profiling Peptide-Level Protease Specificity Using Proteomic Identification of Cleavage Sites (PICS), with Applicability to Protein-Level N-Terminomics.
Journal: Journal of proteome research
Published: March 10, 2026
The Concise Guide to PHARMACOLOGY 2025/26: Transporters.
Journal: British journal of pharmacology
Published: December 29, 2025
Enhanced tumor retention of the novel LAT1-targeting PET probe [18F]FAMT-OMe: A comparative study with [18F]FAMT in glioma mouse models.
Journal: Nuclear medicine and biology
Published: November 30, 2025
Biosynthesis and Export of Membrane-Enveloped Selenium Nanoparticles by Escherichia coli.
Journal: Environmental science & technology
Published: November 21, 2025
L-type amino acid transporter 1 deficiency delays intestinal tissue repair in dextran sulfate sodium-induced colitis.
Journal: International immunopharmacology
Published: April 24, 2025
The crystal structure of the small zinc-finger protein ZifS from Thermus thermophilus HB8.
Journal: Journal of biochemistry
Published: March 19, 2025
Author Correction: The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.
Journal: Scientific reports
Published: February 21, 2025
Sustained reductions in valine and isoleucine mediate anti-cancer pharmacological effects of inhibiting amino acid transporter LAT1 in cancer cells.
Journal: Cancer & metabolism
Published: January 29, 2025
The role of LAT1 in AOM/DSS-induced colorectal tumorigenesis.
Journal: Biochemical and biophysical research communications
Published: November 14, 2024
Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy.
Journal: Scientific reports
Published: November 02, 2024
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.
Journal: International journal of molecular sciences
Published: October 27, 2024
Last Updated: 09/26/2026